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South Africa is home to approximately 20.0% of the global Human Immunodeficiency Virus (HIV) 
infected population. The first reported cases of HIV-1 in the country were described in 1982 amongst 
the homosexual male population. This was attributed to HIV-1 subtypes B (HIV-1B) and D (HIV-
1D). Since the late 1980s HIV-1 subtype C (HIV-1C), spread mainly through heterosexual contact, 
has been the driving force of the epidemic. To date, only six HIV-1B near full-length genome (NFLG) 
sequences from South Africa are available in the Los Alamos National Laboratory database (LANL). 
During this study we retrieved five HIV-1B positive samples from homosexual and bi-sexual males, 
stored for up to 30 years, from the early 1980s, for further characterization. The NFLG amplification 
reactions were performed using a modern Polymerase Chain Reaction (PCR) protocol designed to 
target two overlapping proviral DNA HIV genome fragments, 5.5 kb and 3.7 kb in size, respectively. 
All positive PCR products were sequenced to characterize the viruses. The sequences were checked 
and edited manually using Sequencher V5. Multiple sequence alignments were created using Clustal 
W and Maft V7. The sequences were subtyped using the REGA V3.0, RIP V3.0 and jumping profile 
Hidden Markov Model (jpHMM) online subtyping programmes. Maximum likelihood phylogenetic 
trees were drawn using MEGA V6. Four of the five HIV-1 patient sequences were subtyped as pure 
HIV-1B. One sequence, ZA|85|R605, was characterized as a novel HIV-1 BD recombinant. This is 
the first NFLG HIV-1 BD recombinant ever described and indicates that recombination events were 
most likely already happening at the early stage of the South African epidemic. Two patient 
sequences, ZA|87|R1296 and ZA|87|R459, clusters with HIV-1B sequences from the United States 
of America (USA). The sequence from patient ZA|87|R68 clusters with a HIV-1B sequence from 
France and the sequence of ZA|87|R526 clusters with another South African HIV-1B sequence. 
Homosexual flight stewards, international tourists and migrants from the European and North 
American countries were most likely responsible for the introduction of the HIV-1B epidemic into 
South Africa. The findings of this study provides valuable insights from the beginning of the HIV-1 
epidemic in South Africa. We highlight the importance of characterizing complete viral genomes 
from early archival specimens to give a more detailed picture of landmarks of the HIV/AIDS 
pandemic. We show that NFLG sequencing is an important tool for the identification of recombinant 
viral strains. This study can form the basis for continued research in our attempt to reconstruct the 
epidemiology and evolutionary history of HIV in South Africa. The HIV-1 epidemic is dynamic in 
nature and is constantly changing. 





Suid-Afrika is die tuiste van ongeveer 20,0% van die wêreld se menslike immuniteitsgebreksvirus 
(MIV)-besmette bevolking. Die eerste gerapporteerde gevalle van MIV-1 in die land is beskryf in 
1982 onder homoseksuele mans. Dit was toegeskryf aan MIV-1 subtipes B (MIV-1B) en D (MIV-
1D). Sedert die laat 1980's oorheers MIV-1 subtipe C (HIV-1 C), hoofsaaklik versprei deur 
heteroseksuele kontak. Tot hete is slegs ses MIV-1B naby vollengte genoom (NFLG) rye van Suid-
Afrika beskikbaar in die LANL MIV databasis. Tydens hierdie studie het ons vyf MIV-1B positiewe 
monsters van homoseksuele en biseksuele mans, wat gestoor was vir tot 30 jaar, vanaf die vroeë 
1980's, verder gekarakteriseer. Die NFLG amplifisering reaksies is uitgevoer met behulp van 'n 
moderne  polimerase-kettingreaksie (PKR) protokol ontwerp om twee oorvleuelende provirale DNS 
MIV genoom fragmente, 5.5 kb en 3.7 kb in grootte, te teiken. Alle positiewe PKR produkte se DNS 
volgordes is bepaal om die virusse volledig te karakteriseer. Die volgorde is nagegaan en met die 
hand geredigeer deur gebruik te maak Sequencher V5. Veelvuldige volgorde roetes is geskep met 
behulp van CLUSTAL W en Maft V7. Die MIV-1 subtipes is met die aanlyn programme REGA V5, 
RIP V3.0 en jpHMM bepaal. Die subtipes is bevestig duer maksimum waarskynlikheid filogenetiese 
bome te trek met behulp van MEGA V6. Vier van die vyf MIV-1 pasiënt volgordes is as suiwer MIV-
1B gekarakteriseer. Een volgorde, ZA|85|R605, is gekenmerk as ’n unieke MIV-1 BD rekombinant. 
Tot ons kennis is dit die eerste en enigste NFLG MIV-1 BD rekombinant ooit beskryf en dui aan dat 
rekombinasie gebeure reeds in die vroeë jare van die Suid-Afrikaanse epidemie plaasgevind het. 
Twee pasiënt volgordes, ZA|87|R1296 en ZA|87|R459, is na verwant aan MIV-1B volgordes van die 
Verenigde State van Amerika (VSA). Die volgorde van pasiënt ZA|87|R68 is na verwant met 'n MIV-
1B volgorde van Frankryk en die volgorde van ZA|87|R526 is na verwant aan 'n ander Suid-
Afrikaanse MIV-1B volgorde. Homoseksuele vlug bedienaars, internasionale toeriste en immigrante 
uit die Europese en Noord-Amerikaanse lande was waarskynlik verantwoordelik vir die 
bekendstelling van die MIV-1B epidemie in Suid-Afrika. Die bevindinge van die studie gee insigte 
van die begin van die MIV-1-epidemie in Suid-Afrika. Ons beklemtoon die belangrikheid om argiewe 
MIV-stamme met NFLG volgorde bepalings te karakteriseer aangesien dit vir ons ‘’n meer volledige 
prentjie van die pandemie kan skep, veral uit die begin jare. Ons wys dat NFLG volgorde bepaling 'n 
belangrike instrument is vir die identifisering van rekombinante MIV-stamme. Hierdie studie kan die 
grondslag lê vir voortgesette navorsing om die epidemiologie en evolusionêre geskiedenis van MIV 
in Suid-Afrika te rekonstrueer. 
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Introduction and literature review 
INTRODUCTION 
1.1.1. Brief introduction 
The Human Immunodeficiency Virus (HIV) is the causative agent of Acquired Immune Deficiency 
Syndrome (AIDS). There are two phylogenetically distinct types, that are referred to as HIV type 1 
(HIV-1) and HIV type 2 (HIV-2) (Hirsch et al., 1989; Robertson et al., 2000). HIV-1 is classified 
into four main groups namely; Group M (major), Group N (non-M), Group O (outlier) and Group P. 
HIV-1 group M has nine non-recombinant subtypes designated with letters A-D, F-H, J and K 
(Robertson et al., 2000; Aldrich and Hemelaar, 2012). HIV-1 subtype B (HIV-1B) is a subtype that 
belongs to HIV-1 Group M. Scientific reports have also described several circulating recombinant 
forms (CRFs), unique recombinant forms (URFs) as well as second generation recombinants (SGRs) 
of group M (Aldrich and Hemelaar, 2012). The geographical distribution of group M recombinants 
(78 CRFs and several URFs) throughout the world is not equal 
(http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html accessed 2016 August 30; Aldrich 
and Hemelaar, 2012). HIV-2 is restricted to West African countries (Aldrich and Hemelaar, 2012; 
Essex and Mboup, 2002). CRFs are formed from the recombination of two viral subtypes in at least 
three epidemiologically unlinked individuals and subsequently further transmitted in the population 
(Tebit and Arts, 2011; Lau and Wong, 2013). As an example, recombination between HIV-1 subtypes 
B and F is referred to as CRF_12BF; with the number 12 representing the order in which the CRF 
was described. URFs are known to emerge from the recombination of two or more subtypes which 
do not meet the CRF criteria (https://www.hiv.lanl.gov/content/sequence/HelpDocs/subtypes-
more.html accessed January 10 2017). The long infection period, in conjunction with population 
demographics, has led to the rapid evolution of HIV-1 group M (Aldrich and Hemelaar, 2012). This 
has resulted in a complex classification, worldwide spread and strains intermixing (recombinants) 
(Aldrich and Hemelaar, 2012). From the beginning of the HIV pandemic, an estimated 78 million 
people have been afflicted with AIDS (UNAIDS, 2015). Approximately 35 million people have died 
of AIDS-related illnesses. Sub-Saharan Africa is the most affected region and accounts for almost 
70% of the total new infections globally (UNAIDS 2015).  
 




South Africa has experienced the most devastating effect of HIV/AIDS (UNAIDS, 2015). Evidence 
suggest that the current burden caused by HIV in South Africa is predominantly driven by 
heterosexual transmission of the virus (Fraser-Hurt et al., 2011; Zuma et al., 2016). HIV-1 (group M) 
subtype C (HIV-1C) predominates in South Africa. The initial epidemic in the country, from the early 
1980s, were caused by HIV-1 subtype B (HIV-1B) and D (HIV-1D), spread mainly in the homosexual 
population (Engelbrecht et al., 1995; Middelkoop et al., 2014). Although in minority, HIV-1B is still 
circulating in the country and our laboratory have previously produced evidence of HIV-1BC 
recombinant strains circulating in the Western Cape Province of South Africa (Jacobs et al., 2014). 
The widely accepted hypothesis is that the worldwide introduction and spread of HIV-1B is because 
of human migration from Democratic Republic of Congo (DRC) in Africa into the Haitian population. 
Human movements played a fundamental role in the worldwide dissemination of HIV-1B, which led 
to the viral spread into the diverse population (Gilbert et al., 2007; Junqueira and de Matos Almeida, 
2016). Figure 1 displays the worldwide spread of HIV-1B.  
  






Figure 1: The global dissemination of HIV-1 subtype B (HIV-1B). This diagram shows how HIV-
1B originated from the capital city of Democratic Republic of the Congo (DRC) Kinshasa in Africa. 
The orange lines indicate the direction of the HIV-1 subtype B non-pandemic lineage dissemination. 
The Green regions indicate countries where specific lineages are circulating (Junqueira and de Matos 
Almeida, 2016). 
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1.1.2. HIV-1 spread in South Africa 
In South Africa two separate epidemics have been described; as shown in Figure 2. The first reported 
cases of AIDS in South Africa occurred in 1982, which was initially spread by homosexual men 
(Kuster et al., 1994; Sher, 1989; Engelbrecht et al., 1995; Van Harmelen et al., 1997; Loxton et al., 
2005; Jacobs et al., 2007). Until 1987, HIV-1 was still diagnosed almost exclusively in men. This 
was later identified as HIV-1B and D (Engelbrecht et al., 1995; Loxton et al., 2005; Jacobs et al., 
2007).  
 
Figure 2: The Spread of HIV-1 in South Africa.  This diagram illustrates the critical role of human 
migration played in the spread of HIV-1 in South Africa (adopted from Prof. Susan Engelbrecht). 
 
The second stage of the epidemic was first described in the year 1988 when an increasing number of 
HIV-1C viral sequences were diagnosed in heterosexual females. In 1992, the number of new cases 
in females was roughly equivalent to those in males (Engelbrecht et al., 1995; Van Harmelen et al., 
1997). HIV-1C has been responsible for the majority of infections in South Africa (Jacobs et al., 
2014). 
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1.2. AIM OF THE STUDY  
The current study is aimed to fully characterize HIV-1B near full-length genome (NFLG) virus 
sequences from the early South African epidemic from the 1980s. Until date, we only have six HIV-
1B NFLG sequences from South Africa and one other African NFLG sequence from Gabon in the 
HIV database Los Alamos National Laboratory (LANL). With advanced molecular techniques, we 
now have the opportunity to expand our knowledge / understanding of the molecular characteristics 
of the start of the HIV epidemic in South Africa. Therefore, NFLG sequences generated from this 
work will serve as an update for the HIV database. NFLG characterization of HIV-1B sequences from 
the beginning of the epidemic, with the previously identified subtype B, may shed light on how HIV 
evolution in South Africa. 
. 
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1.3. LITERATURE REVIEW 
In the following section, retroviruses, the history of HIV-1, origin of the pandemic, morphology, 
organisation of the genome, life cycle as well as subtype distribution of HIV-1B worldwide and in 
South Africa will be briefly discussed. In addition, a brief introduction of the phylogenetic analyses 
that are relevant to the project will be reviewed. 
1.3.1 Retroviruses 
Retroviruses received their name in 1974 (Baltimore et al., 1974; Weiss, 2006). A retrovirus 
possesses a unique enzyme called reverse transcriptase (RT). This unique enzyme uses viral 
Ribonucleic acid (RNA) as a template to make a Deoxyribonucleic acid (DNA) copy, which is then 
integrated into its host genomic DNA (Barre-Sinoussi et al., 1983). Retroviruses are also diploid, 
which means they contain two nuclei acid copies, it possesses a high recombination rate when 
different parental genomes are in the same virus particle (Robertson et al., 1995). Retroviruses were 
initially of little concern as they were not associated with humans and were only identified in 
primates. The perceived opinion changed with the discovery of human-associated retroviruses. The 
classification of human retroviruses is depicted in Figure 3. 
 
Figure 3: Human Retrovirus classification.  Retroviruses are classified into Spumavirinae, 









HIV-1 and HIV-2 
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Retroviruses can be divided into three families: Lentivirinae (HIV-1 and HIV-2), Oncovirinae 
(HTLV-I and HTLV-II) and Spumavirinae. The first human retrovirus isolate was the human 
spumavirus (HSRV) (Barre-Sinoussi et al., 1983). The human spumavirus can be isolated from a 
wide range of mammal’s species and are found worldwide (Bobkov et al., 1998; Ghersi et al., 2015). 
The Oncovirinae family consists of Human T-cell leukemia virus Type I or Type II (HTLV-1 and 
HTLV-II) and has the ability to induce cancerous conditions such as carcinoma (Ammann et al., 
1983; Fahey et al., 1984). HTLV-I are thought to have shared the same origin and transmission as 
HIV-1. HTLV-II was first isolated from a patient’s cells who presented with clinical symptoms of a 
rare form of leukemia (Gallo, 1984). HTVL-II was later hypothesized to have originated from Africa 
and subsequently spread to other parts of the world. It is mostly associated with intravenous drug 
users (IDUs) (Vandamme et al., 1998). The Lentivirinae family of retroviruses includes HIV-1 and 
HIV-2. In primates, they are termed Simian Immunodeficiency Virus (SIV). HIV-2 originated from 
Sooty mangabey and is found exclusively in West Africa (Clavel et al., 1987). Figure 4 indicates the 
migration of SIV into humans and its diversity in both primates and homosapiens. 
  




Figure 4: Phylogenetic tree illustrating the relationship of HIV-1 and HIV-2 in humans with 
respect to primate SIV.  The diagram shows the pattern of cross-species transmission and HIV-1 
genetic diversity classified into groups M, N, O and P. HIV-2 and SIVs. This Figure was adoption 
from (Tebit and Arts, 2011). 
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1.3.2 The history of HIV-1  
AIDS was first described in the early 1980’s in the United States of America (USA) amongst 
homosexual males. Patients presented with a rare opportunistic microbial infection caused by 
pneumocystis carinii pneumonia and some later develop Kaposi’s sarcoma (MMWR 30, 1981; 
MMWR 31, 1981; Gottlieb et al., 1981; Friedman-Kien, 1981; Masur et al., 1982). Human 
Immunodeficiency Virus type 1 (HIV-1) was subsequently designated as the etiological agent of 
AIDS by independent research groups in France and the USA in 1983 and 1984, respectively (Barre-
Sinoussi et al., 1983; Popovic et al., 1984).  
The earliest clinical evidence of HIV-1 infection was from samples collected in 1959 from a Kinshasa 
male and also from Norwegian sailors dated in 1971 and 1976 (Zhu et al., 1998; Froland et al., 1988). 
A second diagnosis of HIV-1 was confirmed in Kinshasa collected during 1960, showed variation in 
the HIV-1 env gene compared to the 1959 strain and suggested that HIV had already been diversifying 
and underwent molecular evolution in humans before 1960 (Korber et al., 2000; Worobey et al., 
2008). Based on this data, the latest introduction of HIV into humans can be dated to around 1900 
(1902 to 1921), 20 years earlier than previously estimated (Korber et al., 2000; Worobey et al., 2008). 
The origin of HIV-1 has therefore been a topic of extensive debate in the past (Gao et al., 1999; 
Worobey, 2004). HIV-1 is closely related to SIV from chimpanzees, mainly to strains from the 
subspecies, Pan troglodytes troglodytes (Gao et al., 1999).  
 
1.3.3 The origin of the HIV pandemic 
HIV originated from multiple zoonotic transmissions of SIV from non-human primates into humans 
in West Central Africa, occurring over decades which then resulted in the divergence of the virus 
(Tebit and Arts, 2011; J., 2012). The transmission most likely occurred through hunting and 
slaughtering of primates for bush meat and the capturing of simians as pets (Hahn et al., 2000). 
Phylogenetic evidence has revealed that at least three zoonotic transmissions occurred resulting in 
the HIV-1 M, N and O groups (Figure 1.1) (Sharp et al., 2001; Lemey et al., 2004; Keele et al., 2006). 
HIV-1 group M is responsible for the majority of the infections worldwide (Lemey et al., 2004; 
Hemelaar, Gouws, Peter D Ghys, et al., 2011). Researchers have also found evidence of an O-like 
virus in gorillas (SIVgor), which further supports the theory of a common ancestor being shared 
between primates and homosapiens (Keele et al., 2006). Furthermore, group O and P viruses share 
similarities and suggest that the natural hosts of gorilla infections were Pan troglodytes chimpanzees 
(Plantier et al., 2009). Group O and P is likely to have been derived from independent transmissions 
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of SIV from gorillas (SIVgor) to humans. This seems likely for group P as it clusters closely with 
SIVgor in phylogenetic analysis. Thus far only two people have been identified with HIV infections 
from group P and occurred so far in Yaoundé, Cameroon (Plantier et al., 2009; Vallari et al., 2011). 
HIV-2 is endemic in West Africa and it has limited spread outside West Africa (Clavel et al., 1987). 
HIV-2 is characterized by a longer asymptomatic state, lower viral loads and lower mortality rates as 
compare to HIV-1 (Clavel et al., 1987).  
1.3.4 HIV-1 morphology and genome organisation  
The HIV-1 virion is cylindrically shaped and surrounded by an external bi-lipid layer membrane, as 
shown in Figure 6. It is approximately 120nm in diameter (Gallo, 1984; Novitsky et al., 1999). The 
viral Envelop is a bi-lipid layer derived from budding of the virus from its host cell (Gallo, 1984). 
The Envelope protein is covered with the outer trimeric surface glycoprotein (gp120) and 
transmembrane glycoprotein (gp41) as a result of the precursor protein (gp160) (Turner and 
Summers, 1999). A Matrix (MA) protein (p17) appears on the inside of the lipid bi layer shell which 
forms the inner surface (Turner and Summers, 1999). Capsid (CA) protein (p24) layer forms the 
conical capsid (Girard et al., 2011). The genome is a full length diploid linear ribonucleic acid (RNA) 
(Freed, 2015). HIV-1 enzymes inside the genome are Protease (PR), Reverse Transcriptase (RT) and 
Integrase (IN). Figure 7 displays the HIV-1 genomic organisation. HIV-1 also has structural proteins 
which are called; Trans-Activator of Transcription (Tat) and Regulatory of virion expression (Rev). 
Regulatory genes are also classified as accessory genes which include Viral protein unique (vpu), 
Viral protein R (vpr), Viral infectivity factor (vif) and Negative regulatory factor (nef) (Girard et al., 
2011; Freed, 2015). The gene functions are outlined in Table A. 
  





Figure 5 A: Schematic diagram of the HIV-1 virion.  The diagram gives a transactional view of 
the HIV virion and displays the virus matrix encloses the capsid, which protects the two copies of 
genomic RNA, reverse transcriptase, integrase and protease. The Envelope consists of protruding 
glycoprotein gp120, which stems from the fusion protein gp41. This figure was obtained from 
http://www.infohow.org/science/biology-ecology/hiv-viron/, accessed 2016-08-12. 
 
Figure 6: Outlay of HIV genes, and morphology: The image illustrates the genetic composition of 
HIV and the proteins produced by each gene. MA-Matrix (p17); CA-Capsid (p24); NC-Nucleocapsid 
(p7); PR (P10); RT-Reverse transcriptase (p66), IN-Integrase (p32), SU- Surface subunits (gp120), 
TM- transmembrane subunit (gp41) obtained from the (Costin, 2007). 
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Table A: HIV gene names proteins and their functions. Table A contains information compiled 
from (Graves et al., 1988; Jaskólski et al., 1991; Stanley et al., 2008; Mascarenhas and Musier-
Forsyth, 2009; Kopietz et al., 2012; Solbak et al., 2013; Freed, 2015). The expression of the full 
genome requires multiple frame shifts to synthesize mRNA from overlapping genes (Holmes, Zhang 
and Bieniasz, 2015).  
 






Gag 55 Precursor protein for MA, CA and NC 
Matrix (MA) 17 Attaches to the inner cell membrane. 
Binds RNA to the plasma membrane 
Capsid (CA) 24 Encloses the viral genome 
Nucleocapsid 
(NC) 




Protease (PR) 11 Proteolytic processing of the Gag and 







Conversion of viral RNA into viral DNA  




gp160  160 Precursor for gp120 and gp41 
gp120 120 Co-receptor (CCR5/CXCR4)binding 
gp41 41 Help with the fusion of virus membrane 






27-35 Optimizes T-cell stimuli and down 
regulates CD4 regulation 
Viral protein R 
(Vpr) 
14 Enhance HIV-1 replication 
Viral protein 
unique (Vpu) 
16 Enhances interaction with Tetherin 
Viral infectivity 
factor (Vif) 







14 Initiates transcription by binding 
integrated viral DNA 
 Regulatory of 
virion expression 
(Rev) 
18 Regulates viral replication by a controlled 
translocation of unspliced and spliced 
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1.3.5 The HIV-1 life cycle 
Entry of HIV into the host cell depends on the cell surface receptors molecules CD4 and co-receptors 
CCR4 and CCR5 (Freed, 2015). Once inside the cell, HIV is uncoated and viral RNA is reverse 
transcribed by the Reverse Transcriptase (RT) enzyme into pro-viral double stranded DNA and 
subsequently transported to the cell nucleus (Pomerantz and Horn, 2003). RT inhibitors can block 
this process. At this stage Integrase (IN) aids integration of viral DNA into host genomic DNA and 
renders the infection irreversible (Freed, 2015). IN inhibitors can block this process and prevent the 
infection step. Finally, the virus can synthesize the viral protein by its effective use of host machinery 
and enzymes. New virions are produced by the assembly and budding through the infected cell 
membrane (Pomerantz and Horn, 2003). 





Figure 7: The HIV lifecycle.  The stages of viral lifecycle shown above. Thin, dark arrows show 
entry and integration. Curved and slightly bent arrows show early and late replication. 1- A piece of 
genetic material surrounded by protein. 2- Adsorption to the CD4 receptor (CXCR4 or CCR5). 3- 
Fusion and un-coating of a viral genomic dimer. 4- Reverse transcription. 5- Integration of pro-viral 
DNA into host genome using the integrase enzyme. 6- Transcription of viral DNA Nuclear import of 
PIC. 7- Assembly of viral chain 8- Viral budding, protease enzyme starts the formation of a new 
virus. 9- Breaking off the immature virus. 10- Viral maturation and formation of the new virus 
(Pomerantz and Horn, 2003; Freed, 2015). 
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1.3.6 The epidemiology of the HIV pandemic  
The year 2016 marks 35 years of the AIDS pandemic since its discovery in 1981. In 2015, the United 
Nations AIDS foundation (UNAIDS) estimated that 36.7 (34.0 – 39.8) million people are currently 
living with HIV, with 2.1 (1.8 – 2.4) million new HIV infections in 2015 globally (UNAIDS, 2015). 
Due to the massive antiretroviral therapy (ART) upscale, there has been a decline in AIDS-related 
deaths ranging from 1.2 (990,000 – 1.4) million in 2014 to 1.1 (940,000 – 1.3) million in 2015 
(UNAIDS, 2015). The recent decline has been encouraging to the public health society. Southern and 
East Africa is the worst affected by HIV with approximately 20.5 million people infected with the 
virus (UNAIDS 2015).  
 
Source: http://www.unaids.org/ 
Figure 8 : Illustration of the AIDS pandemic in 2015.  The map indicates the global spread of HIV 
and indicates the areas most affected namely East and Southern Africa. Patients include Adult and 
Children (UNAIDS 2015). 
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1.3.7 The epidemiology of HIV-1 in South Africa 
South Africa currently has the largest AIDS epidemic profile in the world as a result of poverty, 
diverse cultural beliefs, females subjected to sexual abuse, limited primary health care and education 
in rural areas (Mayosi et al., 2014; UNAIDS, 2015). By December 2015, approximately 7.0 (6.7 – 
7.4) million people were infected with HIV in South Africa. HIV-1 was most prevalent in the 
KwaZulu-Natal (KZN) province with a prevalence of 27.6%. The Western Cape (WC) province has 
the overall lowest prevalence of approximately 9.2% three times lower than KZN (Delva and Karim, 
2014). In South Africa, only 3.4 million people are currently receiving ART (UNAIDS 2015). 
Patients receiving ART have a greater improvement in terms of life expectancy and morbidity 
(UNAIDS 2015). 
1.4 Distribution of HIV-1 group M subtypes 
HIV-1 group M has a high genetic variability and HIV-1 subtypes are not evenly distributed 
worldwide (Aldrich and Hemelaar, 2012). Most of the Group M subtypes are genetically linked and 
human migration plays a vital role in the dissemination and spread between neighbouring countries 
(Gao et al., 1998). Subtype A was first identified in the sub-Saharan Africa (Tebit and Arts, 2011). It 
has also been identified in Russia and many Western countries (Tebit and Arts, 2011). HIV-1B is 
more predominant in Europe, North America, Southeast Asia, Middle East and Australia (Junqueira 
and de Matos Almeida, 2016; Magiorkinis et al., 2016). HIV-1C is most dominant subtype in 
Southern Africa, similar to East Asia (Jacobs et al., 2014; Wilkinson et al., 2015). HIV-1D was first 
isolated in a Zairian student in Alabama and the strain was fully sequenced in the USA which 
highlights the fact that almost all HIV-1 subtypes are of Africa origin (Graves et al., 1994; Puren, A, 
2002). HIV-1D has since been isolated in Uganda, Kenya, Tanzania South Africa and Cuba 
(Thomson, Pérez-álvarez and Nájera, 2002). Subtype F has been described in Belgium, Romania and 
South America (Thomson, Pérez-álvarez and Nájera, 2002). Subtype J and H have been isolated in 
Central Africa, Cyprus, Greece and Cuba (Thomson, Pérez-álvarez and Nájera, 2002; Loxton et al., 
2005; Tebit and Arts, 2011). 
  




1.4.1 The emergence of the HIV-1B epidemic 
The HIV-1B common ancestral strain most likely originated in Kinshasa (Faria et al., 2014). 
Phylogenetic and historical evidence indicates that HIV-1B has been circulating in the region since 
1944 (1935 – 1951) (Faria et al., 2014). The spread of the subtype B lineage and epidemic initially 
began outside Africa around 1966 (1962 – 1970) (Gilbert et al., 2007). In the 1960s, approximately 
4500 Haitian professionals were sent to work in Congo. The majority of the immigrants were teachers 
and bureaucrats (Junqueira and de Matos Almeida, 2016). The subsequent political crisis and Belgian 
congo in the city of Kinshasa led to migration of the Haitian professionals back to Haiti (Piot et al., 
1984; Pepin, 2011; Crowder, 1984). In 1979, Haitians analyzed hospitalized patients with AIDS-
related symptoms; the first AIDS case was only confirmed in 1983 (Malebranche et al., 1983; Pape 
et al., 1983). Initially, the HIV-1B viral dissemination in Haiti was predominantly identified with the 
men who have had sex with men (MSM) risk group (Wheeler and Radcliffe, 1994; Gilbert et al., 
2007; Worobey et al., 2008; Junqueira and de Matos Almeida, 2016). Over a period of time the nature 
of the epidemic has changed and reached the heterosexual population and recipients of blood 
transfusion in Haiti (Junqueira and de Matos Almeida, 2016). 
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1.4.2 Spread and global distribution of HIV-1B  
HIV-1B occupies a vital position in various continent epidemiological profiles and successfully been 
dispersed across the globe (https://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.comp 
accessed on the 25th of August 2016).  It is currently the only subtype circulating in several countries 
of each continent all over the world 
(https://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.comp accessed on the 25th of August 
2016). Figure 9 shows that the LANL HIV database has over 609128 sequences in total and has 
approximately 339370 HIV-1B sequences accounts for 55.71% across the globe. Only seven of these 
full-lengths sequences are from Africa (LANL accessed 2016 August 30). Global distribution of HIV-
1B have been reviewed  by Lukashov et al., 1996; Bobkov et al., 1998; Robertson et al., 2000; Liebert 
et al., 2000; Nabatov et al., 2002; Guimara et al., 2007; Arán-Matero et al., 2011; Hemelaar, Gouws, 
Peter D Ghys, et al., 2011; Junqueira et al., 2011; Pagán and Holguín, 2013; Cabello, Mendoza and 





Figure 9: Illustrates the current distribution of HIV-1 subtype sequences as found in the LANL 
HIV database.  Most recent subtype sequences according to distribution, population and spread 
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across the continent. The green portion represents the worldwide distribution of HIV-1 subtype B 
across the globe. Adopted from the LANL HIV database 
(https://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.comp, accessed 2016 August 30). 
1.4.3 HIV-1B pandemic and non-pandemic clades 
The earliest evidence of HIV-1 introduction into the USA emerged approximately in 1969 (Junqueira 
and de Matos Almeida, 2016). Several studies identified a high HIV-1B prevalence in MSM amongst 
the Americans and Haitians living in America (Laverdiere and Lavallee, 1983; Selik et al., 1984; 
Robbins et al., 2003; Gilbert et al., 2007; Junqueira and de Matos Almeida, 2016). The HIV-1B rate 
of infection has increased exponentially amongst the MSM population that formed the bridge between 
both countries (Kuiken et al., 2000; Pape et al., 1983). In the mid-1970s, the capital city of Haiti, 
Port-au-Prince, was a popular tourist destination for homosexual Americans, mostly from the New 
York Metropolitan area, in search of sex tourism (Pepsin, 2011).  
In the United States, the rate of infection was higher amongst homosexuals than heterosexuals 
(Paraskevis et al., 2009; Beyrer, Baral and Griensven, 2012; Beyrer et al., 2013; Patel et al., 2014). 
This could be due to the higher incidence of anal intercourse as opposed to vaginal intercourse, as 
most infections in MSM are transmitted through unprotected receptive anal intercourse (URAI) (Patel 
et al., 2014). Social connection and the international relation between countries played a vital role in 
the spread of HIV-1B to most parts of the world, including South Africa. The introduction of the virus 
because of high-risk behavior explains the successful establishment of HIV-1B epidemic in other 
parts of the world. (Kuiken et al., 2000; Perrin, Kaiser and Yerly, 2003). 
In the early 1970s, a secondary non-pandemic outbreak originated in Hispaniola Island. By the 1980s, 
it had spread across the majority of the South and Central American countries, including Trinidad 
and Tobago, Jamaica, Mexico, Venezuela, Panama, Columbia, Ecuador, El Salvador, Honduras 
Suriname and Brazil (Cabello, Junqueira and Bello, 2015; Junqueira and de Matos Almeida, 2016). 
These clades reflect virus circulation in culturally related countries, which gives rise to transmission 
networks. The transmission in most cases often results in dead-end infection due to the combination 
of chance and multifaceted socio-ecological factors (Cabello, Junqueira and Bello, 2015).  
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1.4.4 The HIV-1B epidemic in South Africa 
The origin of HIV-1 in South Africa began with HIV-1 subtype B and D in the homosexual risk group 
(Sher, 1989; Becker, De Jager and Becker, 1995; Engelbrecht et al., 1995). HIV-1B was introduced 
into the country by homosexual males that worked as flight stewards and tourist traveling within 
North America and European countries (Engelbrecht et al., 1995). The second phase of HIV infection 
occurred in the late 1980s where the epidemic was diagnosed amongst heterosexuals (Engelbrecht et 
al., 1995; Van Harmelen et al., 1997; Harmelen et al., 1999). In the early 1980s subtype B is almost 
exclusively seen in homosexual males in South Africa (Sher, 1989; Becker, De Jager and Becker, 
1995; Engelbrecht et al., 1995; Loxton et al., 2005; Jacobs et al., 2007). There have been cases of 
heterosexual HIV-1 B described within our laboratory (Dr. Jacobs, personal communication).  
Currently, HIV-1C is the dominant subtype circulating in South Africa. HIV-1 has been studied by 
Becker, De Jager and Becker, 1995; Engelbrecht et al., 1995; Van Harmelen et al., 1997; Harmelen 
et al., 1999, 2001; zur Megede et al., 2002; Treurnicht et al., 2002; Gordon et al., 2003; Hunt et al., 
2003; Rousseau et al., 2006; Jacobs et al., 2008, 2014; Wilkinson and Engelbrecht, 2009. 
Almost four decades since the first recognition of HIV-1 in South Africa only six HIV-1B NFLG 
genomes have been fully characterized, in contrast to HIV-1C NFLG genomes (LANL accessed 2016 
August 30; Engelbrecht et al., 1995; Van Harmelen et al., 1997; Loxton et al., 2005; Rousseau et al., 
2006; Wilkinson et al., 2015; Junqueira and de Matos Almeida, 2016; Magiorkinis et al., 2016). 
In 2014, HIV-1 BC recombinants were reported circulating in South Africa (Jacobs et al., 2014). In 
2015, HIV-1B strain closely related to the ancient strains from the USA was also reported occurring 
in the heterosexual population, which indicates epidemic crossover (Middelkoop et al., 2014; 
Wilkinson et al., 2015). Considering the circulation of HIV-1 recombinant forms, there is now an 
increasing need for continuous HIV-1 subtype surveillance, as different subtypes can influence drug 
resistance and disease progression. This could be achieved through NFLG sequencing (Middelkoop 
et al., 2014; Wilkinson et al., 2015). Understanding HIV-1 diversity in South Africa could play an 
important role in monitoring the HIV-1 epidemic and in developing prevention and treatment 
strategies (Aldrich and Hemelaar, 2012; Wilkinson et al., 2015). 
  




1.5 Phylogenetic analysis of HIV 
1.5.1 Concepts of molecular evolution 
The science of evolution was first described in the 1800s when naturalists became fully aware that 
species have changed but were not sure of what changed and where the change originated. The 
reconstruction of evolutionary history of organisms presented in the form of a phylogenetic tree has 
been the main drive of all biologists ever since the time of Charles Darwin (Ayala and Fitch, 1997). 
The main cause behind evolution is due to mutational changes of genes. Mutational changes can occur 
when there is a nucleotide change caused by either a substitution, insertions or a deletion (Hartl and 
Clark, 1997). A phylogenetic tree consists of various components, which are interdependent of each 
other. The node is connected to the branches and the branch base represents the distance between the 
nodes (Nei and Kumar, 2000; Vandamme, 2003).  
1.5.2 Multiple alignments 
When raw sequences are obtained, it is important that sequences be checked for potential 
contaminants. In the absence of contamination, sequences need to be checked for errors and 
assembled into contiguous fragments (contigs). Multiple sequences that are similar has to be aligned 
in such a way that homologous sites appear in the same column (Siepel et al., 1995; Chenna et al., 
2003). Sequences differ in length and gaps in some position are used to achieve alignment. 
Alignments are required for other analyses such as to demonstrate sequence similarity within a group 
of family sequences (Chenna et al., 2003). Software programs that are commonly used to do 
alignments are Clustal W (Thompson, Higgins and Gibson, 1994; Larkin et al., 2007). MAFT v7 
(http://mafft.cbrc.jp/alignment/server/). Clustal X program (Chenna et al., 2003; Larkin et al., 2007). 
  




1.5.3 Nucleotide substitution models 
The fundamental evolution concept of DNA sequences is nucleotide substitution (transition and 
transversions) (Graur and Li, 1999). Scientist has developed models that take into consideration 
different parameters, such as base frequencies, in order to efficiently study the dynamics of nucleotide 
substitution (Graur and Li, 1999). The most commonly used models till date are Jukes-Cantor (Juke 
et al., 1969), the more advanced General Time Reversible model (Rodriguez et al., 1990), Kimura 2 
parameter (Ng et al., 2013), Felsenstein 81 (Felsenstein, 1985) and Hasegawa-Kishino-Yano HKY85 
(Takahashi and Nei, 2000). There are many reviews available on the various models. Examples in the 
literature are Felsenstein, 1985; Saitou and Nei, 1987; Steel and Penney, 2000; Takahashi and Nei, 
2000; Society, 2010; Civetta, Ostapchuk and Nwali, 2016; Yoshida and Nei, 2016. 
1.5.4 Neighbour joining (NJ) trees 
Neighbour Joining (NJ) is a tree building method that is based on a minimum principal of evolution 
(Saitou and Nei, 1987). NJ is a clustering algorithm that combines speed and accuracy. This method, 
at each stage of taxon clustering, uses a minimum evolution principal, but does not examine all 
possible topologies. The neighbours (in this instance HIV sequences) are defined as two taxa, in an 
unrooted tree that are connected to a single node. The algorithm tree produced begins with a star tree, 
which is produced under the impression that there are no clustering of taxa (Saitou and Nei, 1987; 
Nei and Kumar, 2000).  
1.5.5 Maximum Likelihood Trees 
For Maximum Likelihood (ML) approach to tree inference, the tree selected is the tree that gives the 
highest probability that produces the input sequence alignment (Takahashi and Nei, 2000). For every 
single tree, the likelihood of producing input alignment of each site is usually calculated by 
probabilities of summing every possible ancestral state. The likelihood at each site is the product of 
likelihood for the full tree. ML trees optimize the fit between the tree and the data as it searches for 
the topology that gives rise to the input dataset (Steel and Penney, 2000). 
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The study was aimed to characterize NFLG sequences from identified HIV-1 B strains from the 
1980s, representing the early HIV-1 epidemic in South Africa. We characterized the viral strains 
through NFLG amplification, sequencing and detailed phylogenetic analysis. This chapter explains 
the methodologies that were used to approach the study objectives. Figure 10 illustrates the workflow 
breakdown of the methods used throughout this project. 
 
 
Figure 10: Flow chart illustrates the methodologies used for near full-length genome (NFLG) 
characterisation of HIV-1B cohort from South Africa. 
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 2.2 Reagents and equipment 
The list of chemical reagents, equipment, and software application that were used during the course 
of this study are listed in this chapter. In Table B - D shows the commercial product, equipment and 
software packages frequently used to perform the experiment.  
Table B: List of chemical and commercial products used in the study. 






QIAamp DNA Blood Mini 
Kit 
DNA extraction Qiagen, Germany 51106 
KAPAHiFi  
Ready-mix (2X) Hot start 
PCR experiment KAPA 
Biosystem, USA 
A 1260 
Nuclease free water All experiment Qiagen, Germany 145045078 
Agarose Gel electrophoresis Lonza, USA #D1 - LE  
6x Blue Orange Loading 
Dye 
Loading PCR amplicons Promega, United 
States of America 
G 1881 
QIAquick PCR Purification 
Kit 
PCR amplicons clean-up Qiagen, , 
Germany 
28 106 
BigDyeTM Terminator cycle 
sequence ready Kit 
Sequencing PCR  Applied 
BioSystems,  
USA 
4 337 035 
5x Sequencing Buffer Sequencing PCR  Applied 
BioSystems, USA 
4 305 603 
BigDye XTerminator 
Purification Kit 
Sequencing clean-up kit Applied 
BioSystem, USA 
4 374 408 
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Table C: Equipment used for sample analysis 
Piece of Equipment Application/ 
Methods 
Supplier Location 
GeneAmp PCR System 9700 
thermal cycler 
PCR experiment Applied 
BioSystems 
USA 
Nanodrop™ ND 1000 Spectrophotometric 
measurement of 





GeneAmp® 9700 PCR 
system thermal cycler 
PCR experiment Applied 
Biosystems 
USA 
UV-ITEC Prochem Gel 
Dock System  
Gel visualization 







Liquid and solid 
separation 
Eppendorf  Germany 
ABI prism® 3130XL 






Table D: Software packages and online tools used for sequence analysis  
Software package References and/or licensed companies 
Sequencher v 5 Gene Codes Corporation,, USA 
ClustalW v 2.1 Thompson et al., 1997 
MEGA v 5.0 Tamura et al., 2011 
MAFFT v.7 http://mafft.cbrc.jp/alignment/server/  
(accessed  on 2016/10/31) 
BioEdit http://www.mbio.ncsu.edu/BioEdit/bioedit.html 
(accessed on 2016/11/01) 
jpHMM Spang et al., 2002 (accessed on 2016/10/31) 
REGA v 3.0 HIV subtyping 
tool 
de Oliveira et al., 2005 (accessed on 2016/10/25) 
v -version 
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2.3 Ethical considerations 
The study received ethical approval from the Human Research Ethics Committee (HREC) at the 
Faculty of Medicine and Health Sciences, Stellenbosch University (Tygerberg Campus) under a main 
study entitled “Tracking the molecular epidemiology and resistance pattern of HIV-1 in South 
Africa”, which is been renewed annually. The ethics approval letter is attached in Appendix A, ethics 
reference number N15/08/071. 
2.4 Study population and sample selection 
Since 1984 genomic DNA extracted from HIV-1 patients were obtained at the Tygerberg Academic 
Hospital in the Western Cape. In this study, we selected five previously identified HIV-1 B samples 
from South Africa, collected for further characterisation. All five samples included in this study were 
collected during the 1980s from homosexual males. The samples were partially sequenced in the env 
gene by Prof. Susan Engelbrecht (Engelbrecht, 1992). Sequences were co-cultured with donor 
peripheral blood mononuclear cells (PBMCs) obtained from healthy HIV negative individuals. High 
molecular weight (hmw) genomic DNA was sequenced from virus-infected cell cultures and stored 
at -20oC. The current study used the same DNA from the earlier study (Engelbrecht et al., 1995). The 
patient demographics are summarised in Table E. 





Year of birth Gender Risk factors Origin of 
sample 
1 R68 15/09/1987 1961 Male Homosexual Western Cape 
2 R526 22/09/1987 1955 Male Bi-sexual Western Cape 
3 R605 01/11/1985 1956 Male Homosexual Western Cape 
4 R459 02/11/1987 1954 Male Bi-sexual Western Cape 
5 R1296 30/10/1987 1938 Male Homosexual Western Cape 
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2.5 Polymerase chain reaction (PCR) 
HIV-1 NFLG amplification was performed in two overlapping fragments, (Figure 11). The first 
fragment (F1) is from gag to vpu position relative to HXB2 (0776 > 6231) approximately 5.5kb in 
length. The second fragment (F2) starts from the vpu to the3’LTR position relative to HXB2 (5550 > 
9719) approximately 3.7kb in length. Figure 11 shows a schematic diagram of the amplification 
strategy as outlined by (Grossmann, Nowak and Neogi, 2015).  
 
(Grossmann, Nowak and Neogi, 2015) 
Figure 11: The amplification strategy.  The diagram shows amplification for whole genome. Full 
genome amplification was achieved by amplifying DNA in two fragments. Four primers were used 
for each fragment utilising pre-nested and nested PCR. Fragment 1 consisted of genes starting from 
gag to vpu and was approximately 5.5Kb in length. The second fragment of genes starting from vpr 
until the 3’LTR and was approximately 3.7kb in length. The following paragraphs below describe 
each fragment in more detail.  
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2.5.1 Fragment 1 (F1) Gag-Vpu 
Amplification of the gag-vpu gene fragment was achieved through two rounds of PCR using the high 
fidelity KAPA HiFi Hot Start Ready Mix (2 x) (KAPA Biosystems, USA). Reactions were performed 
in a final volume of 50µl. Primers for first round (0682F and 6352R) and second round PCR (0776F 
and 6231R) were used at an initial concentration of 10µm. Table F indicates the reaction composition 
for both the pre-nested and nested PCR master mixes. 
Table F: Master Mix used for the amplification of the first fragment of HIV-1 







KAPA Hi-Fi Hot Start Ready-
mix  
2X 25ml 1X 25.0μl 
Forward Primer (0682F/0776F) 10μM 2.0ml 
 
300nM 1.5μl 
Reverse Primer (6352R/6231R) 10μM 2.0ml 
 
300nM 1.5μl 
Template DNA variable variable 5ng 5μl 
PCR Grade H2O  17.0μl 
Total volume  50.0µl 
 
The cycling conditions used for F1 are indicated in Table G. The same cycling conditions were used 
for both first and second round PCR reactions. A GeneAmp PCR System 9700 thermal cycler (Perkin 
Elmer, Boston, USA) was used to perform the PCR reactions. 
Table G: Cycling parameters of F1 (first and second round PCR) 
Cycling conditions Cycle Temperature in ºC Time 
Initial Denaturation 1X 1 95 5 minutes 
Denaturation 30 98 20 seconds 
Annealing 65 15 seconds 
Elongation 72 3 minutes 
Final elongation 1 72 5 minutes 
Reactions were stored at 4ºC until used. 
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2.5.2 Fragment 2 (F2) Vpu- 3’LTR 
The amplification reactions were performed using the high fidelity KAPA HiFi Hot Start Ready Mix 
(2X) (KAPA Biosystems, USA) Reactions were performed in a total volume of 50µl. Primers for pre-
nested (5550F and 9555R) and nested PCR (5861F and SQ2R) were used at an initial concentration 
of 10µM. The preparation of the master mix for F2 was identical to F1, refer to Table F for the master 
mix composition. Cycling conditions for F2 are indicated in Table H. The same cycling conditions 
were retained for both pre-nested and nested PCR reactions. A GeneAmp PCR System 9600 thermal 
cycler (Perkin Elmer, Boston, MA, USA) was used to perform the PCR reactions. 
Table H: Cycling parameters of second fragment (first and second round PCR) 
Cycling conditions Cycles Temperature in ºC Time 
Initial Denaturation  1 95 5 minutes 
Denaturation 30 98 20 seconds 
Annealing 65 15seconds 
Elongation 72 2 minutes 
Final elongation 1 72 5 minutes 
Reactions were stored at 4ºC until used. 
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Table I shows primers name and sequences obtained from (Grossmann, Nowak and Neogi, 2015). 
and SQ2R was obtained from (Rousseau et al., 2006). Primer 0440R is an in house primer designed 
in order to get a more specific amplification for F2. Human Immunodeficiency Virus Subtype B strain 
(HXB2) was selected because this virus is the most commonly used reference strain for many 
different kinds of functional studies, nucleotide position to determine position of the primers. 
Table I. Primer used for PCR amplification both of fragment 1 and fragment 2 
Primer 
name 
Sequence (5’- 3’) HXB2 position 
0682F TCTCTCGACGCAGGACTCGGCTTGCTG 0682→0708 
0776F CTAGAAGGAGAGAGAGATGGGTGCGAG 0776→0800 
6352R GGTACCCCATAATAGACTGTRACCCACAA 6352→6324 
6231R CTCTCATTGCCACTGTCTTCTGCTC 6231→6207 
5550F AGARGAYAGATGGAACAAGCCCCAG 5550→5574 
5861F TGGAAGCATCCRGGAAGTCAGCCT 5861→5884 
9555R TCTACCTAGAGAGACCCAGTACA 9555→9533 
SQ2R TAGAGCACTCAAGGCAAGCTTTATTGAGGCTTA 9202→9221 
0440R CCAGAGCTCACCTAGCACCATCCAAAGGTCAGTGGG 9238→9201 
 
2.6 Agarose gel electrophoresis 
Agarose gel electrophoresis separates DNA fragments according to their size. The separation of DNA 
molecules happens by applying an electric field to a gel matrix. A 0.8% agarose gel was prepared by 
completely dissolving 0.80g of molecular grade agarose (Invitrogen, USA) in 100 ml of 1 X Tris-
Acetate-EDTA (TAE) buffer, which was heated in the microwave oven. The 1 X TAE buffer was 
prepared from a stock of already prepared 50 X TAE buffer. Molten agarose was stained with 10μl 
of GR green [New England Biolabs, United Kingdom (UK)]. Subsequently, poured into a plastic gel 
electrophoresis tank and allowed to set at room temperature.  Five microliter (5µl) of each PCR 
product, mixed with 1µl of 6 x loading dye (Thermoscientific, USA), was loaded into gel lanes and 
run alongside negative and positive controls and a 1kb molecular weight DNA marker (Promega, 
USA). DNA was resolved by electrophoresis at 75 Volts for 50 minutes. The resolved DNA fragments 
were visualized with the Alliance Chemilluminscence and Fluorescence gel imaging system (UVItec, 
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UK). The expected fragment sizes for the first fragment, F1 (gag-vpu) and second fragment, F2, (vpu-
3’LTR) were 5.5kb, and 3.5kb respectively.  
2.7 DNA purification  
Visualized positive PCR products were purified. Briefly, DNA purification was achieved using two 
separate purification methods. The first method was performed using Direct PCR purification with 
the QIAquick PCR purification kit (Qiagen, Germany). The second purification method was carried 
out using QIAquick gel extraction kit (Qiagen, Germany) for PCR product that had multiple bands 
visible on the gel. Purification was done according to the manufacturer’s instructions, both methods 
are described below. 
2.7.1 QIAquick PCR purification method (Direct PCR 
purification) 
The first method was performed using the QIAquick PCR purification kit (Qiagen, Germany). 
Briefly, in a clean 1.5ml centrifuge tube, 115μl of solubilisation buffer (buffer QG) was added to 5 
volumes of PCR product. The resulting mixture was transferred into a mini elute column and 
centrifuged at 13000 revolutions per minute (rpm) for 1 minute (Eppendorf Centrifuge 5424R, 
Germany), allowing the binding of viral DNA to the gel matrix column. The flow-through was 
discarded. A volume of 750μl of wash buffer (buffer PE) was added to the column and centrifuged at 
13000 rpm for 1 minute. The flow through was discarded in order to remove residual buffer. The 
column was centrifuged at 13000 rpm for 1 minute and the collection tube discarded. The column 
was placed in a clean 1.5ml centrifuge tube and 45μl of elution buffer (buffer EB) was added to the 
centre of the column. The column assembly was incubated at room temperature for 3 minutes and 
centrifuged at 13000 rpm for 1 minute. The column was discarded and the purified DNA product was 
confirmed by resolving a 2μl aliquot of the product on a 0.8% agarose gel-by-gel electrophoresis.  
 2.7.2. QIAquick gel extraction method  
The second purification method used was agarose gel extraction with the QIAquick gel extraction kit 
(Qiagen, Germany). Briefly, 45µl of the PCR product was loaded on a 0.8% agarose gel and subjected 
to electrophoresis. A sterile blade was used to excise the band of interest under a dual intensity 
ultraviolet transilluminator (Uvp Inc, USA). The excised band was placed in a nuclease free 1.5ml 
centrifuge tube and weighed (Mettler instrumente, Switzerland). Subsequently, 300μl of buffer QG 
was added to the excised gel thereafter incubated at 50°C with pulse vortexing (Heidolph, Germany), 
for complete dissolution of the gel. A 100μl of aliquot isopropanol was added to the dissolved gel to 
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precipitate the DNA. The mixture was added to a spin column which was placed into a collection 
tube and centrifuged at 13 000 rpm for 1 minute in the Eppendorf centrifuge 5424R (Eppendorf, 
Germany). Once the DNA bound to the membrane of spin column, the flow through was discarded. 
An extra centrifugation step was performed at 13 000 rpm to remove residual buffer. The column was 
placed in a clean micro-centrifuge tube and 45μl of Buffer EB was added to the centre of the column 
to elute the DNA. The column assembly was incubated at room temperature for 3 minutes and 
centrifuged at 13 000 rpm for 1 minute. The purified products were confirmed by resolving a 2μl 
aliquot of the product on a 0.8% agarose gel-by-gel electrophoresis. 
2.8 Sequencing of near full-length genome (NFLG) of HIV-1 
Purified DNA products concentration were determined on the ™ND1000 Spectrophotometer 
(Nanodrop technologies, USA). Primers used for the sequencing are indicated in Appendix 2. 
Sequencing primers were diluted to a final concentration of 5µmol with nuclease free water (Qiagen 
Germany). For each sequencing reaction mixture, the composition was as follows: 1.0µl of the 
BigDye® X Terminator Enzyme mix, 3.0µl of 5X reaction buffer, 1.0 µl of each primer at a 
concentration of 5µmol, 1.0µl of purified DNA and 4.0µl nuclease free water to a final volume of 
10µl. Table J illustrates the cycling parameters of the PCR sequencing assay. Whole genome 
sequencing primers consisted of a combination of in house designed primers and primers described 
by Rousseau et al., 2006; see attached in (Appendix 2). The sequencing PCR products were purified 
using the BigDye® XTerminator Purification kit and analysed on an ABI 3130XL genetic analyser 
(Applied Biosystems, USA). The ABI 3130XL is a polymer-based capillary electrophoresis 
sequencer connected to a computer with sequencing analysis software (Applied Biosystems, USA) 
and captures raw data trace files. Raw data trace files in the form of sequences chromatograms were 
retrieved from the 3130XL ABI Prism genetic analyser and imported into Sequencher version 5.0 
(Gene Codes Corporation, USA). Sequences with poor quality ends were removed from overlapping 
nucleotide sequences to improve the quality of the sequences and assembled into a single contig file. 
Assembled contig files were screened for ambiguities, edited, exported and saved in fasta format as 
a text file (.txt). 
Stellenbosch University  https://scholar.sun.ac.za
35 
 
Table J: sequencing PCR cycle parameters 
Cycling conditions Cycles Temperature in °C Time 
Initial denaturation 1 95 60 seconds 
Denaturation 25 95 60 seconds 
Annealing 55 7 seconds 
Elongation 60 4 minutes 
Reactions were stored in 4°C until further used 
 
 2.9 Sequence quality control 
The nucleotide sequences were verified for stop codons, insertion and deletions using an online 
quality control tool on the HIV LANL. HIV BLAST was used to find sequences similar to patient 
sequences. Thereafter, patients sequences were characterized and subtyped using the Jumping Profile 
of Hidden Markov Model (jpHMM), Recombinant Identification Program (RIP) v 3.0and REGA v3.0 
phylogenetic analysis (http://www.hiv.lanl.gov/content/sequence/QC//index.html). 
 
 2.10 Characterization of sequences using online HIV 
subtyping tools 
Three online subtyping tool were used for data analyses namely; REGA version 3.0, jumping profile 
Hidden Markov Model (jpHMM), and Recombinant Identification Program (RIP) v 3.0. All three 
subtyping tool make use of different algorithms. Results obtained from each tool gives an idea of 
what subtype our query sequences. Results obtained from each subtyping tool were subjected to 
phylogenetic analyses to confirm the reliability of the patient sequence subtype. 
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2.10.1 REGA version 3.0 subtyping analysis 
REGA (http://bioafrica.mrc.ac.za:8080/rega-genotype-3.0.2/hiv/typingtool#/) is an online genetic 
subtyping tool that makes effective use of bootscanning methods and phylogenetic analysis to detect 
recombination and subtype of specific gene fragments. The tool is able to analyses 1000 sequences 
at any given time and has been previously used to characterize HIV-1 subtypes. REGA is also 
accessible from the LANL webpage (http://www.hiv.lanl.gov/). (de Olivera et al., 2005)  
2.10.2 Jumping Profile Hidden Markov Model Analysis 
(jpHMM) 
The jumping profile Hidden Markov Model (jpHMM) (http://jphmn.gobics.de/) is a method that 
compares query nucleic acid or protein sequences to a family of sequences in a jumping alignment 
approach (Spang et al., 2002). A single query sequence is therefore aligned and compared to different 
sequences of a single alignment. This approach simplifies the identification of recombinant events as 
breakpoints of recombinant isolates will be compared to different sequences in the alignment (Zhang 
et al., 2006; Schultz et al., 2009). 
2.10.3 Recombinant Identification Program (RIP) version 3.0 
The Recombinant Identification Program (RIP) (http://www.hiv.lanl.gov) is an online program that 
provides a summary of information to describe large sets of sequences. This online program makes 
use of two program options. The first option is an “informative mode” which when activated counts 
only informative positions. The informative position is the position at which at least one subtypes 
consensus sequence differs from the other in related to a central or reference position. The second 
option relates to the handling of gaps. Gaps in RIP can either be “squeeze” or “strip.” RIP will only 
squeeze gaps that are not in position where query or all subtype consensus sequences are represented 
by a gap. Gaps can be strip gaps which means that it ignores position at which the query or any 
subtype consensus sequences is represented by a gap (Siepel et al., 1995). 
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2.10.4 Multiple alignments of query and reference sequences 
HIV-1 subtypes complete genome reference sequences were retrieved from the LANL 
(http://www.hiv.lanl.gov) database. Alignments of the reference sequences were done using Clustal 
X (Larkin et al., 2007). All multiple alignments were converted to Mega format (. meg). The Genbank 
Accession number and family subtype was used to label all the reference sequences. 
2.10.5 Model test 
Model test is an important test performed on aligned sequences when you intend to draw a Maximum 
likelihood (ML) phylogenetic tree. In order to know which test should be used to generate the 
phylogenetic tree a model test must be carried out on the aligned query sequences and the reference 
sequences. This test is carried out on Molecular Evolutionary Genetics Analysis (MEGA) v6.06. 
Lowest BIC scores were considered as the best model test (Tamura et al., 2013). The lowest BIC for 
each samples were the General Time Reversible (GTR) with a discrete Gamma distribution by 
assuming that a certain site is evolutionary invariable (I). 
2.10.6 Construction of ML trees 
 MEGA version 6.06 was used to analyze converted MEGA files (.meg) (Tamura et al., 2013). Model 
tests were carried out using MEGA v6.06. Lowest Bayesian Information Criterion (BIC) scores are 
considered to describe the best substitution pattern. Oftentimes, the model with the lowest BIC when 
constructing a ML tree are General Time Reverse Gamma distributed with invariant sites 
(GTR+G+I), General Time Reverse Gamma distributed (GTR+G), The accuracy of the generated 
tree was validated by bootstrap analysis with a total of 1000 bootstrap replicates for each dataset. 
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3.1 Introduction  
This chapter focuses on NFLG analysis of the HIV-1B samples and sequences obtained for my study. 
PCR amplification were performed on selected samples. The samples were amplified in two separate 
fragments (F1 and F2) and yielded approximately 9kb. Subsequently, amplicons were sequenced and 
generated sequences were analyzed and subtyped using various online subtyping tool. Finally, 
phylogenetic analysis was performed on the complete sequence dataset for full characterization of 
HIV-1B NFLG sequences. 
3.2 DNA quantification and PCR amplification of the HIV-1 
genome 
Table L shows selected samples DNA concentration as determined on the Nanodrop. The 
concentration ranges from 156 μg/μl.and the purity ranges from 302 μg/μl. Subsequently, NFLG PCR 
amplification were performed on the selected samples for the study. Table L below gives a brief 











Stellenbosch University  https://scholar.sun.ac.za
40 
 
3.3 PCR amplification  
 
Table K: Nanodrop concentration, PCR amplified and sequenced amplicons 


















1 R1296 156 Yes Yes Yes Yes 
2 R526 187 Yes Yes Yes Yes 
3 R68 179 Yes Yes Yes Yes 
4 R459 275 Yes Yes Yes Yes 
5 R605 302 Yes Yes Yes Yes 
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Positive amplicons were confirmed to be the right size (~5.5kb) with reference to the positive control. 
Absence of a band in the negative control well confirmed the absence of contamination Figure 12A 
shows ~5.5 kb PCR amplicons and Figure 12b shows~3.7 kb PCR amplicons. 
A 
 
Figure 12: A 0.8% agarose gel of F1. The gel shows a visible, specific band of the F1 (~5.5kb) in 
size for five patient amplicons, negative template control (NTC), Positive control (PC) and 1KB 
ladder. The amplified ~5.5kb fragments were purified.  
12 B 
 
In Figure 12 B: A 0.8% agarose gel electrophoresis. This gel shows a visible, specific amplification 
of the F2 (3.7kb) in size for five patient amplicons, negative template control (NTC), Positive control 
(PC) and 1KB ladder. Amplification was achieved using two sets of primers in two rounds of PCRs. 
The amplified 3.7kb fragments were purified. 
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3.4 DNA sequencing 
Five amplicons with both fragments were amplified through PCR and subsequently sequenced using 
the ABI automated sequencer. Direct sequencing of the second fragment consumed more time and 
was more challenging due to the variability in the env gene. Figure 13 shows an example of the 
sequence chromatogram of the env gene region. The env gene is the least conserved region of the 
HIV-1 genome. It is always constantly under attack by the host immune system because it helps with 
the fusion of virus membrane to the host cell membrane. In response, the virus make use of its 
glycoprotein to protect itself by mutating the env gene. The read lengths of the five NFLG sequences 
were at an average of approximately 8797bps. See Tables 3.3 – 3.6 for detailed information on gene 
annotation for each sample. Sequences with quality below 75% were removed and sequences were 
trimmed from edges to remove low-confidence base calls. Gene specific primers were designed to 
sequence and fill in the missing gaps to give readable sequences. The sequencing primers are listed 
in Appendix 2. 
 
 
Figure 13: A snapshot of sequencer chromatogram of the env gene. The F2, which includes the 
env gene gave problematic sequences and was hard to read. New gene specific primers were 
designed to help compensate for the problem.  
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3.5 Sequence analyses 
 3.5.1 Assembling of NFLG  
Sequences were checked for quality control and quality scores between 75 and 90% were obtained to 
form NFLG contigs. Sequences were trimmed at the edges to remove low-confidence base calls and 
were manually edited using the Sequencher v5 software. Sequences with high quality were manually 
assembly. Thereafter, they were put together to form contigs. Figure 14 shows snapshot from 





Figure 14: A snap shot of HIV-1 genome sequencing from Sequencher v5. The green arrows 
represent the forward primers; the red arrows represent the reverse primers. The sequences were 
mapped against the HXB2 reference strain. 
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 3.5.2 Annotation of genes 
In order to have an indication of the start and end point of each viral gene, gene annotation were done 
for all NFLG sequences relative to the HXB2 reference strain. Tables M – Q The HIV/SIV sequence 
locator on the HIV database was used for annotation of each viral gene. All the query viral genes are 
similar in length compared to HXB2 sequences from LANL. ZA|85|R68 has premature stop codons 
in the env gene. The env encodes for the Envelope protein located at the outer shell membrane of the 
virus. In response to the host immune attack the env gene mutates to avoid attack from host immune. 
The stop codons are at the following positions env 370, 383 with no frameshift detection. ZA|86|R526 
has three frameshifts at the following positions assesory gene vif 173, vpr 2, and nef 144 with no 
premature stop codons. ZA|86|R605 also has no premature stop codon, but with 5 frameshift detected 
at the respective positions gag 417, pol 3, env 81, env 728 and nef 126 ZA|85|R459 has 3 frameshifts 
at the respective positions gag 1, rev 79, and env 775 with no premature stop codons. ZA|87|R1296 
has 3 frameshifts at the following position in the env 194, env 466 and nef 142 with no premature 
stop codons. It is important to know that the HIV/SIV sequence locator might give misleading results 
in cases where the query sequences have an insertion or a deletion. Sequence alignment should be 
done in order to be certain with the sequence integrity. 
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Sample ZA|85|R68 sequence starting position relative to HXB2 complete genome starts from the gag 
at position 886 and ends at the nef at position 8825. The following online subtyping tool; jpHMM, 
REGA and RIP were used in Figure 15 for sample ZA|85|R68 sequence analysis’s in order to fully 
characterize the sequence.  
 
Table L: Nucleotide position on the HIV genome relative to sample ZA.85.R68 
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Sample ZA|87|R526 sequence starting position relative to HXB2 complete genome starts from the 
gag position 886 and ends at the nef position 8825. The following online subtyping tool; jpHMM, 
REGA and RIP were used in Figure 16 for ZA|87|R526 sequence analyses in order to fully 
characterize the sequence. 
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Sample ZA|85|R605 sequence starting position relative to HXB2 complete genome starts from the 
gag position 849 and ends at the nef position 9175. The following online subtyping tool; jpHMM, 
REGA and RIP were used in Figure 17 for the ZA|87|R605 sequence analyses in order to fully 
characterize the HIV-1 genome.  
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Sample ZA|85|R459 sequence starting position relative to HXB2 complete genome starts from the 
gag position 849 and ends at the rev position 8539. The following online subtyping tool; jpHMM, 
REGA and RIP were used in Figure 18 for the ZA|87|R459 sequence analyses in order to fully 
characterize the HIV-1 genome. 
 












Stellenbosch University  https://scholar.sun.ac.za
49 
 
Sample ZA|85|R1296 sequence starting position relative to HXB2 complete genome starts from the 
gag position 1054 and ends at the 3’LTR position 9719. The following online subtyping tool; jpHMM, 
REGA and RIP were used in Figure 19 for the ZA|87|R1296 sequence analyses in order to fully 
characterize the HIV-1 genome. 
 
Table P: Nucleotide position on the HIV genome relative to sample ZA. 87. R1296 
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3.6 Online subtyping analyses of HIV-1 
In order to fully characterize each of the sample sequence online subtyping tool such as RIP, jpHMM 
and REGA were used to comprehensively analyse samples selected for the purpose of the study. 
Figure 15 – Figure 19 represent a visual description of each sequence analyses and the genome 
subtype. All the online subtyping tool used in the following; Figure 15, 16, 18 and 19 confirms the 
NFLG as a pure subtype B except for ZA|85|R605. In Figure 17 ZA|85|R605 is confirmed as a HIV-
1 BD recombinant with the following break points; gag = D, pol = B; env = B. There is a discrepancy 
with the nef 3’LTR – RIP and REGA says B, while jpHMM says K, A1. In order to have a 
comprehensive analysis of the sample we drew a phylogenetic tree for each regions of the genome.  
 
 
Figure 15: Analysis of sample ZA|85|R68 using three online HIV-1 subtyping tool 15A: RIP; 
15B: REGA; and 15C: jpHMM. All the three HIV-1 online subtyping tool indicates gag = B, pol = 
B; env = B; nef = B and 3’LTR= B. In order to validate the online subtyping tool result, we drew a 
phylogenetic tree for NFLG of HIV-1B. 
  




Figure 16: Analysis of sample ZA|87|R526 using three online HIV-1 subtyping tool.  16A: RIP; 
16B: REGA; and 16C: jpHMM. All the three HIV-1 online subtyping tool indicates gag = B, pol = 
B; env = B; nef = B and 3’LTR= B. In order to validate the online subtyping tool result, we drew a 




Figure 17: Shows analysis of sample ZA|85|R605 using three online HIV-1 subtyping tool.  17A: 
RIP; 17B: REGA; and 17C: jpHMM. gag = D, pol = b; env = b; Discrepancy with the nef 3’LTR – 
RIP and REGA says B, while jpHMM says K, A1. In order to have a comprehensive analysis of the 
sample we drew a phylogenetic tree for each regions of the genome. The breakpoints are listed in 
Table O. 




Figure 18: Analysis of sample ZA|87|R459 using three online HIV-1 subtyping tool. 3.5A: RIP; 
3.5B: REGA; and 3.5C: jpHMM. All the three HIV-1 online subtyping tool indicates gag = B, pol = 
B; env = B; nef = B and 3’LTR= B. In order to validate the online subtyping tool result, a phylogenetic 
tree was drawn for NFLG of HIV-1B. 
 
 
Figure 19: Analysis of sample ZA|87|R1296 using three online HIV-1 subtyping tool.  19A: RIP; 
19B: REGA; and 19C: jpHMM. All the three HIV-1 online subtyping tool indicates gag = B, pol = 
B; env = B; nef = B and 3’LTR= B. In order to validate the online subtyping tool result, we drew a 
phylogenetic tree for NFLG of HIV-1B. 
Stellenbosch University  https://scholar.sun.ac.za
53 
 
3.7 Phylogenetic analysis  
In a phylogenetic tree, epidemiologically related sequences that share a common or recent ancestor 
should cluster together. In order to define the phylogenetic connection amongst the NFLG sequences 
of R68, R1296, R526, R459 and R605 we performed a total of nine multiple alignments. In Figure 
20, the ML phylogenetic tree shows the NFLG analyses of patient sequences in comparison to NFLG 
group M subtype reference without recombinants. The second NFLG phylogenetic tree in Figure 21 
phylogenetic tree shows the NFLG analyses of patient sequences in comparison to other subtype B 
sequences. Reference sequences selection criteria was based on HIV BLAST results with closely 
related sequences to the patient sequences. Additional reference sequences were obtained from 
Worobey et al., 2016. 
The NFLG ML phylogenetic analyses of patient sequences indicate that reference viral sequences are 
related with significant statistical bootstrap value of 99%. Patient sequences clusters together with 
subtype B reference sequences at the top of the phylogenetic tree. Sequence of patient ZA 86. R526 
clusters with USA strain from 1979 with GenBank accession number KJ 704791. Sequence of patient 
ZA.85. R68 clusters with the USA strain from 1986 with GenBank accession number AY 835771. 
Sequence of patient ZA.85. R459 clusters with the USA strain from 1986 with GenBank accession 
number M93259 through a BLAST search. Sequence of patient ZA.87. R1296 clusters with the 
Netherlands strain from 1986 with GenBank accession number AY 970947 through a BLAST search. 
Additional HIVB reference sequences mostly from the New York and San Francisco in the USA were 
obtained from Worobey et al., 2016.  These sequences probably cluster together as HIV-1B epidemic 
in South Africa is thought to have come from contacts in the USA and Europe. In addition, HIV-1B 
clade sequences from Haiti, Trinidad and Tobago obtained from (LANL accessed 30th of August 
2016). Sequence of patient ZA.86. R605 is a HIV-1 subtype B outlier, which support the presence of 
BD recombinant at the start of the epidemic. 
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3.8 NFLG analysis 
Figure 21 presents ML phylogenetic evaluation of patient NFLG sequences with HIV-1B and HIV-
1D reference sequences obtained from the LANL HIV database. These sequences are amongst the 
oldest HIV-1B NFLG identified. HIV-1B reference sequences were obtained from South Africa, 
USA, France, Haiti and Trinidad and Tobago. Reference sequences selection criteria were based on 
the role that each country played with the spread of HIV-1B. We also included five HIV-1D 
sequences from South Africa due to the identification of the novel HIV-BD recombinant sequence 
from patient ZA|85|R605. Four of the five patient samples are marked at the tree node with a rectangle 
and the sequence from sample ZA|87|R1296 is marked by a triangle. The sequence from sample 
ZA|85|R605 is a subtype B outliner. This sample clusters in between reference sequence from the 
USA, with the year and ascension number 2005|B|US|2005|01226, and reference sequence 
1983|D|CD|193|ELI with a 100% bootstrap value. The sequence from sample ZA|87|R526 clusters in 
between sequences from South Africa, with the year and ascension number 
B|ZA|1985|R84|FJ647145, with a 100% bootstrap value. The sequence from sample ZA|87|R68 
clusters in between reference sequence with the year and ascension number B|FR|1983|HB2-LAI-
IIB-BRU and 1983|PZ|04053R84 with a 100% bootstrap value as well. The sequence from sample 
ZA|87|R1296 clusters in between reference sequence from South Africa and the USA with the year 
and ascension number B|ZA|2000|TV047|KJ94866 and B|US|1983|SF2 LAV2 ARV2. The sequence 
from sample ZA|87|R459 clusters in between reference sequences from New York in the USA. This 
reference sequence is amongst the oldest HIV-1B strains identified by Worobey et al., 2016, with the 
year and ascension number |B|US|1979|4NY79. Subgenomic phylogenetic analysis illustrates that the 
sequence from sample ZA|85|R605 is a HIV-1 BD recombinant, Figure 24 – 27.  




Figure 20: A ML phylogenetic tree of HIV-1 NFLG sequences. The analysis involved 38 
nucleotide sequences. Bootstrap values greater than 70% are shown at the main nodes. Position 
according to HXB2 (849 – 9719). Horizontal scale 0.1 scale was used for the branch lengths. 
  

















































Figure 21: A ML phylogenetic tree of HIV-1 NFLG sequences. Bootstrap values greater than 70% 
are shown at the main nodes. Position according to HXB2 (849 – 9719) Horizontal scale 0.02 scale 
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3.9 Phylogenetic sub-genomic fragment analysis of sample 
ZA.85.R605 
In order to have a comprehensive analysis the sequence of sample ZA|85|R605. We drew a ML 
phylogenetic tree for each break point on the HIV-1 genome with respect to jpHMM. Figure 22 – 25 
show the phylogenetic analysis according to the subtype break points as indicated in Figure 17. The 
















Figure 22: A ML phylogenetic tree of the sequence of sample ZA|85|R605. Bootstrap values 
greater than 70% are shown at the main nodes. Position according to HXB2 (1010 – 2152). Horizontal 






































Figure 23: A ML phylogenetic tree sequence of sequence ZA|85|R605 subtype B  Bootstrap values 
greater than 70% are shown at the main nodes. Position according to HXB2 (2152 – 3626) Horizontal 





































Figure 24: A ML phylogenetic tree of sequence ZA|85|R605 subtype D.  Bootstrap values greater 
than 70% are shown at the main nodes. Position according to HXB2 (3626 – 5324) DNA sequences. 




































Figure 25: A ML phylogenetic tree of the sequence of sample ZA|85|R605.  Bootstrap values 
greater than 70% are shown at the main nodes. Position according to (HXB2 5324 – 8379). Horizontal 
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Chapter 4  
Discussion 
4.1 Introduction 
 In this section, we discuss the significance of the data generated from this study. The five HIV-1B 
samples used for this study were previously genotyped in the env region from patients infected 
through homosexual transmission during the 1980s (Engelbrecht et al., 1995). The samples were fully 
sequenced and characterized during this study. Four of the five HIV-1 NFLG sequences were 
characterized as pure HIV-1B. One identified as an HIV-1BD recombinant. An evolutionary 
phylogenetic approach was used in the analyses of the sequences with reference sequences obtained 
from the HIV database, LANL. The HIV-1BD recombinant identified is a novel recombinant strain 
and represents the first and only NFLG HIV-1BD sequence analysed thus far. It is the only NFLG 
HIV-1BD recombinant in the world.  
 
4.2 The HIV-1 epidemic in South Africa 
Phylogenetic analyses of the NFLG sequences in Figure 21 shows that all the archival samples 
clusters with the South African, North American and European strains. The results generated from 
this study are in agreement with studies that suggest that the HIV-1B was first introduced into South 
Africa by the Europeans and the North Americans (Engelbrecht et al., 1995; Van Harmelen et al., 
1997). Homosexual flight stewards, international tourists and migrants from the European and North 
American countries were most likely responsible for the introduction of HIV-1B epidemic into South 
Africa (Engelbrecht et al., 1995; Van Harmelen et al., 1997), refer to Figure 2. 
In South Africa two independent epidemics have been described (Engelbrecht et al., 1995; Van 
Harmelen et al., 1997; Loxton et al., 2005). Scientific reports indicate that in the mid-1980s HIV-1B 
was predominantly circulating amongst the white MSM and HIV-1C amongst the heterosexual 
population (Van Harmelen et al., 1997). Online subtyping programmes used for characterization of 
the archival samples shows, that the findings from this study further strengthen the hypothesis of the 
presence of HIV-1B amongst the homosexual risk group at the beginning of the epidemic in South 
Africa, refer to Figure 16 – 19. Furthermore, to the best of our knowledge we are reporting for the 
first time HIV-1BD recombinant, at the beginning of the epidemic, refer to Figure 17.  
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Scientific reports during the early days regularly used smaller gene portions to characterize HIV-1 
subtypes, which could have limited the identification of recombinant viral strains. These archival 
samples were stored as hmw DNA at -20°C for long-term storage purposes by Prof. Susan 
Engelbrecht. With the advancement of molecular techniques and the availability of archival samples, 
we managed to characterize a recombinant strain from the beginning of the epidemic.  
Jacobs et al conducted a study in 2009 in which 22 out of 320 (6.9%) sequences were characterized 
as HIV-1B. In 2014, Jacobs et al., 2014 also reported the presence of HIV-1BC recombinant strains 
in the Western Cape Province of South Africa. Middelkoop et al., (2014) also reported the presence 
of HIV-1B and HIV-1C circulating amongst the MSM in South Africa. In 2015 HIV-1B strains that 
were closely related to ancient strains from the USA were reported to be circulating in the 
heterosexual population, which indicates epidemic crossover (Middelkoop et al., 2014; Wilkinson et 
al., 2015). All these findings further strengthen the hypothesis that the state of HIV-1 epidemic in 
South Africa is constantly changing.  
4.3 The significance of the HIV-1B epidemic in SA and Africa 
Limited information is available for HIV-1B sequences from South Africa. Only six NFLG HIV-1B 
sequences from South Africa are available in the LANL HIV database (Wilkinson et al., 2015; 
https://www.hiv.lanl.gov/components/sequence/HIV/search.comp, accessed 2016 August 30). Four 
out of the six are from the Stellenbosch University Tygerberg Virology Division and Wilkinson et 
al., 2001, 2015, describe these strains. Rousseau et al., 2006, have described one of the six. Hora et 
al (https://www.hiv.lanl.gov/components/sequence/HIV/search.comp accessed 2016 August 30) 
described the latest sequence. In Africa, there is only one other published NFLG sequence from 
Gabon (Huet et al., 1989). The last HIV-1B NFLG was sequenced in 2009, which means that for the 
past seven years not much focus has been placed on NFLG of HIV-1B in both Africa and South 
Africa. The HIV-1B from Gabon shows no phylogenetic relationship with any of the South African 
HIV-1B sequences. The sequence was most closely related to the 1980s strains from the USA with 
GenBank ascension number AY835781 and with the Netherland strains from 1986 with GenBank 
ascension number U34603. Although the infection occurred in the 1980s, analyses of ancestral 
sequences are critical to understanding the time of origin of the early epidemic in the country 
(Wilkinson et al., 2015).  
Stellenbosch University  https://scholar.sun.ac.za
65 
 
4.4 The significance of NFLG sequences of HIV 
HIV-1 NFLG sequencing provides important data that is essential for understanding viral evolution 
and the pathogenesis of HIV infection (Rousseau et al., 2006; Grossmann, Nowak and Neogi, 2015). 
Previous molecular epidemiological studies have repeatedly used smaller (for example gag, pol and 
env) or partial genes to evaluate HIV-1 forms of recombination (Neogi et al., 2012; Grossmann, 
Nowak and Neogi, 2015). Previous studies have stressed the importance of NFLG to validate major 
HIV-1 circulating recombinant forms (Wilkinson and Engelbrecht, 2009; Jacobs et al., 2014; 
Wilkinson et al., 2015). Therefore, the effective use of NFLG as a tool for HIV-1 subtyping is 
important to understand the dynamic of the HIV epidemic within different populations (Gall et al., 
2012; Grossmann, Nowak and Neogi, 2015; Wilkinson et al., 2015). The NFLG sequencing protocol 
developed from this study has been used to characterize our HIV-1BD URF.  
Previously developed NFLG protocols are either disadvantaged by low quantity, which is often 
limited to a particular HIV-1 subtype or does not amplify proviral DNA (Rousseau et al., 2006; 
Grossmann, Nowak and Neogi, 2015). This protocol has successfully amplified four major subtypes 
and recombinant forms (HIV-1B, HIV-1C, 01_AE, BD and 02_AG) which are collectively 
responsible for more than 80% of global infections (Hemelaar, Gouws, Peter D. Ghys, et al., 2011; 
Grossmann, Nowak and Neogi, 2015).  
Over the years, there have been several approaches to develop NFLG protocols. Fang et al., (1996) 
developed two different NFLG protocol strategies: the first protocol targeted to amplify a 9-kb 
fragment, whilst the second protocol targeted to amplify two overlapping 5 kb fragments. Both 
protocols were developed from plasma viral RNA for efficient HIV-1 NFLG cloning, using reverse 
transcriptase and long PCR amplification strategies. NFLG protocols were also developed by Gao et 
al., (1996), who directly sequenced the amplicons, without first cloning.  
Recent approaches with next-generation sequencing (NGS) platforms have revolutionized the field 
of HIV-1 NFLG sequencing and analyses. NGS provides exceptional possibilities for large-scale 
sequencing. NFLG protocols using NGS platforms has been described by (Archer et al., 2012; Gall 
et al., 2012; Grossmann, Nowak and Neogi, 2015). The feasibility of NGS platform in low middle-
income countries (LMICs) has been limited due to cost. Currently, there are several platform options 
accessible for NGS, such as Ion Torrent and Illumina. It is important that we consider developing 
NGS protocol for complete genome amplification suitable for our setting. 
Stellenbosch University  https://scholar.sun.ac.za
66 
 
4.5 The HIV-1 epidemic in South African homosexual males 
The current HIV research emphasis in South Africa has been on the heterosexual and vertical 
transmission (Middelkoop et al., 2014). There has been little information about HIV-1 subtypes 
circulating in the homosexual risk group (Middelkoop et al., 2014). The impact of homosexual 
transmission patterns in South Africa may be minor, however it cannot be ignored (Middelkoop et 
al., 2014). In the mid 80’s and 90’s, due to the political segregation of apartheid, inter-racial 
relationships were prohibited and different cultural backgrounds may have influenced the identity 
and activity of heterosexuals (Middelkoop et al., 2014). Over the past decades changing sociopolitical 
landscapes and behavioral patterns have played a significant role in the spread of the epidemic 
(Abecasis et al., 2013; Hawke et al., 2013; Takebe et al., 2014; Junqueira and de Matos Almeida, 
2016). The change in behavioral evidence formed a link between heterosexuals and homosexuals 
(Middelkoop et al., 2014). Recent studies have described the presence of unique inter-subtype 
recombinants such as BC, BF, and AC in both homosexuals and heterosexuals (Jacobs et al., 2014; 
Middelkoop et al., 2014; Wilkinson et al., 2015). Wilkinson et al (2015) also support the theory of a 
link between the homosexual and heterosexual population. All these findings strengthen the theory 
of a potential epidemic crossover. The presence of a BF sequence and a rare F2 sequence is also a 
cause for concern because it shows the increasing presence of recombinant strains in South Africa 
(Middelkoop et al., 2014). Countries in different regions of the world have full documentation of 
HIV-1 strains circulating amongst the homosexual population and HIV-1B prevalence has been 
reported in the homosexual risk groups all over (Arán-Matero et al., 2011; Abecasis et al., 2013; 
Hawke et al., 2013; Takebe et al., 2014; Junqueira and de Matos Almeida, 2016). HIV-1B 
dissemination in various parts of the country has been largely influenced by the change in sexual 
orientation (Junqueira and de Matos Almeida, 2016). Asia has witnessed a dramatic genotype switch 
as opposed to other parts of the world (Kato et al., 2003; Tee et al., 2005; Kondo et al., 2013). To 
date, limited studies have been aimed at understanding the origin and spread of HIV-1B in 
homosexuals (Chen et al., 2011; Kondo et al., 2013; Ng et al., 2013; Takebe et al., 2014; Junqueira 
and de Matos Almeida, 2016).  
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4.6 HIV-1 subtype D in South Africa 
There are in total 79 NFLG pure HIV-1D sequences; only seven (8.8%) of these are sequences from 
outside Africa (https://www.hiv.lanl.gov/components/sequence/HIV/search/search.comp, accessed 
on the 21/11/2016). Engelbrecht et al (1995), from our laboratory, described five HIV-1D viruses 
from South Africa. Apart from these five not a lot of focus has been placed on the virus from this 
country (Loxton et al., 2005; Jacobs et al., 2007). In 1997, HIV-1D was identified in a male 
homosexual patient and one heterosexual patient through partial gag analysis (van Harmelen et al., 
1997). Bredell et al., (2002) conducted a study where he identified an HIV-1 CD recombinant. The 
Democratic Republic of Congo (DRC) has reported a high prevalence of HIV-1D (11.5%) as 
compared to South Africa and many other African countries (Vidal et al., 2000). According to Jacobs 
et al., unpublished data from Stellenbosch University Tygerberg Virology, our laboratory has also 
identified the presence of possible HIV-1CD recombinant in the country. Wilkinson et al., (2015) 
characterized an NFLG URF HIV-1AD strain from South Africa. The NFLG characterization of HIV-
1BD is an indication that viral diversity was present at the beginning of the epidemic.  
4.7 Strengths and limitations 
One of the strengths of the study was the ability to amplify the NFLG of archive samples using high 
efficient, modern molecular techniques. Such improvements are reflected by the successful 
troubleshooting and optimization of NFLG PCR reactions and the designing of gene-specific primers 
suitable for the NFLG sequencing. The optimized NFLG protocol can potentially be used in large-
scale population-based molecular epidemiological studies. It can also be implemented in the clinical 
laboratory management of drug resistance genotyping with the advantage of amplifying full-length 
Gag-Pol for determining predictors of PI, RT and IN drug mutation, as well as genotypic co-receptor 
tropism testing for co-receptor antagonists. The protocol will also help fill in the gap for more NFLG 
sequences because partial HIV-1 sequences may underrepresent viral recombinant forms. Sequencing 
of the env gene was challenging and significant amount of time was lost. The study limitations include 
the scarce availability of archive ancestral samples. As the sample volumes are often limited, we have 
one chance to apply our NFLG protocol to obtain valuable sequence data. Thus, these stored samples 
need to be handle with great care. In addition, the protocol has only been optimized for proviral DNA 
amplification and not viral RNA.  
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4.8 Ongoing / Future work  
This study forms the basis for continued research in our attempt to reconstruct the epidemiology and 
evolutionary history of HIV in South Africa. In the current study, we did not investigate epidemic 
crossover (for example, we did not include samples from different time points) due to time constraints 
and availability of funds. Future work can focus on looking at the transmission clusters and looking 
into how the epidemic has spread from the beginning until now. We are also planning to perform 
NGS on these archive amplicons to establish that the protocol is not Sanger sequence dependent but 
can be sequenced on both Sanger and NGS platforms. We are also currently in the process of 
optimizing this protocol to amplify NFLG from viral RNA. 
4.9 Conclusion 
This work represents the most recent analyses of archival HIV-1B sequences from the early South 
African epidemic. Our results highlight the importance of using HIV NFLG sequences to give a more 
detailed picture of early landmarks in the HIV/AIDS epidemic. This study also adds valuable 
information to the origin and history of HIV-1 in South Africa. To the best of our knowledge, we 
have characterised the first HIV-1BD recombinant strain in the world. The presence of HIV-1 BD 
recombinant at the beginning of the epidemic is an indication that viral recombination events was 
happening at the beginning of the epidemic in South Africa, but could have easily been missed as 
sequence analyses were often limited to small genomic regions of HIV. Comprehensive modern 
NFLG sequence analyses can be used as a valuable tool to map the evolutionary path of HIV in South 
Africa. 
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Appendix One  
Ethics approval 
 
















24 58.5 Forward Dr Hackett JR* 
R2051 TATRTTGACAGGTGTAGGT 19 49.5 Reverse Dr Hackett JR 
R2457 CTAAGGGRACTGAAAAATATGC 22 51.7 Reverse Dr Hackett JR 




23 48.7 Forward Dr Hackett JR 
ABB20-10R GGCTAGGTGAATTGCATGTA 20 53.6 Forward Dr Hackett JR 
ABB20-11R TATGTCCATTGGTCTTGCCC 20 55.9 Reverse Dr Hackett JR 
ABB20-3F ATCAGTACAATGTGCTTCCA 20 52.9 Forward Dr Hackett JR 




23 52.9 Forward Dr Hackett JR 
M/O p24-6R TGTGWAGCTTGYTCRGCTC 19 56.1 Reverse Dr Hackett JR 
ppr15 CCTTCTAAATGTGTACAATC 20 46.9 Forward Dr Hackett JR 
cm237F2030 GGAAACCAAAAATGATAGGGGG 22 55.2 Forward Dr Hackett JR 
cm237R2500 GTACTGATATCTAATCCCTGG 21 50.0 Reverse Dr Hackett JR 
cm237R3800 CTGACTAATTTATCTACTTG 20 43.5 Reverse Dr Hackett JR 








23 55.7 Forward Dr Hackett JR 
rtin seq F2 
CAACCAGAYARRAGTGAATCAG
A 




26 54.1 Forward Dr Hackett JR 
 ABB20-2F TAGGTACAGTGTTAGTAGGA 20 49.7 Forward Dr Hackett JR 
ABB20-6F GGCATAGATAAAGCCCAAGAA 21 53.8 Forward Dr Hackett JR 
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28 69.0 Forward 
Salminen et al, 
1995 
G00 GACTAGCGGAGGCTAGAAG 19 53.1 Forward 
Sanders-Buell et 
al, 1995 
G10 CAGTATTAAGCGGGGGAGAATT 22 52.8 Forward 
Sanders-Buell et 
al, 1995 
















GAGAGCGGCGACTGGTGAG 19 60.7 Forward Dr Hackett JR 
ABB55-3-
790R 
AGGCCTTTTCTTCTACTACTTTTA 24 53.3 Reverse Dr Hackett JR 
M/O p24-6R.1 TGTGWAGCTTGYTCRGCTC 19 56.1 Reverse Dr Hackett JR 
M/O p24-2F AGRACYTTRAAYGCATGGGT 20 55.8 Forward Dr Hackett JR 
 
  












      




24 58.3 Forward Dr Hackett JR 
LP7725R.1 GTCCAATGCCAATAAGTCTTGTTC 24 56.1 Reverse Dr Hackett JR 
20env5'2018R TCCCCWTCACTCTCRTTGCCACTA 24 62.3 Reverse Dr Hackett JR 
20env5'1644R CCGGGTGRTTCCAGGGCTCTA 21 63.0 Reverse Dr Hackett JR 
20env5'2287F CTTTGAGCCCATTCCCATACATTA 24 56.7 Forward Dr Hackett JR 
20env-1301F ACTATGGGGTACCGGTGTGGAGA 23 62.8 Forward Dr Hackett JR 
55env222R AATCGCAAAACCAGCTGGAGCAC 23 62.3 Reverse Dr Hackett JR 
55env173R TTGCCTTGGTGGGTGCTATTCCTA 24 62.1 Reverse Dr Hackett JR 




24 62.8 Forward Dr Hackett JR 
env27F AARCCTCCTACTATCATTATRA 22 49.4 Forward Dr Hackett JR 






















27 58.1 Forward 
Sanders-Buell et 
al, 1995 
E80 CCAATTCCCATACATTATTGTG 22 49.1 Forward 
Sanders-Buell et 
al, 1995 






27 62.6 Reverse 
Sanders-Buell et 
al, 1995 
E65 AGTGCTTCCTGCTGCTCC 18 52.4 Reverse 
Sanders-Buell et 
al, 1995 
E145 CAGCAGTTGAGTTGATACTACTGG 24 55.5 Reverse 
Sanders-Buell et 
al, 1995 
      
env-LTR       
ABB55-4-
370F 
AACCCGACAGGCCCGAAAGAA 21 62.7 Forward Dr Hackett JR 
ABB55-4-
1186F 




24 60.9 Forward Dr Hackett JR 
69env-4109F ACATGGGTGGCAAGTGGTCAAAA 23 61.5 Forward Dr Hackett JR 
55-4-1912R CTTTCGGGCCTGTCGGGTTCC 21 63.7 Reverse Dr Hackett JR 
20env 4038R GTACCTGCGGCCTGACTGGA 20 62.4 Reverse Dr Hackett JR 
E220 TATCAAAATGGCTGTGGTATATAA 24 48.7 Forward 
Sanders-Buell et 
al, 1995 






26 54.7 Reverse 
Sanders-Buell et 
al, 1995 
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E270 GTGGAACTTCTGGGACGCAG 20 55.7 Forward 
Sanders-Buell et 
al, 1995 
NefF CCTAGAAGAATAACACAGGGCTT 23 55.3 Forward 
Dept Medical 
Virology+ 



























































































































24 56.0 Forward 
Dept Medical 
Virology 


































































Primer sequences kindly provided by Dr Hackett (Abbott Laboratories, Illinois, USA) before 
publication. Primers obtained from the Department of Medical Virology, Tygerberg campus, 
University of Stellenbosch. 
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